1.
Dubberke, ER, Gerding, DN, Classen, D, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol
2008;29(suppl 1):S81–S92.
2.
Yokoe, DS, Anderson, DJ, Berenholtz, SM, et al. Introduction to “A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates.” Infect Control Hosp Epidemiol
2014;35(5):455–459.
3.
McDonald, LC, Owings, M, Jernigan, DB.
Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis
2006;12(3):409–415.
4.
Miller, BA, Chen, LF, Sexton, DJ, Anderson, DJ. Comparison of the burdens of hospital-onset, healthcare facility–associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol
2011;32(4):387–390.
5.
Zilberberg, MD, Shorr, AF, Kollef, MH. Growth and geographic variation in hospitalizations with resistant infections, United States, 2000–2005. Emerg Infect Dis
2008;14(11):1756–1758.
6.
Lucado, J, Gould, C, Elixhauser, A. Clostridium difficile Infection (CDI) Hospital Stays, 2009. HCUP Statistical Brief 124. Rockville, MD: Agency for Healthcare Research and Quality, 2012. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb124.pdf.
7.
Bauer, MP, Notermans, DW, van Benthem, BH, et al.
Clostridium difficile infection in Europe: a hospital-based survey. Lancet
2011;377(9759):63–73.
8.
Loo, VG, Poirier, L, Miller, MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile–associated diarrhea with high morbidity and mortality. N Engl J Med
2005;353(23):2442–2449.
9.
Miller, M, Gravel, D, Mulvey, M, et al. Health care–associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis
2010;50(2):194–201.
10.
Denno, DM, Shaikh, N, Stapp, JR, et al. Diarrhea etiology in a pediatric emergency department: a case control study. Clin Infect Dis
2012;55(7):897–904.
11.
Feghaly, RE, Stauber, JL, Tarr, PI, Haslam, DB. Viral co-infections are common and are associated with higher bacterial burden in children with Clostridium difficile infection. J Pediatr Gastroenterol Nutr
2013;57(6):813–816.
12.
Rousseau, C, Poilane, I, De Pontual, L, Maherault, AC, Le Monnier, A, Collignon, A.
Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis
2012;55(9):1209–1215.
13.
Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep
2012;61:157–162.
14.
Campbell, RJ, Giljahn, L, Machesky, K, et al.
Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol
2009;30(6):526–533.
15.
Dubberke, ER, Reske, KA, Yan, Y, Olsen, MA, McDonald, LC, Fraser, VJ.
Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis
2007;45(12):1543–1549.
16.
Dubberke, ER, Butler, AM, Yokoe, DS, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol
2010;31(10):1030–1037.
17.
Kim, J, Shaklee, JF, Smathers, S, et al. Risk factors and outcomes associated with severe Clostridium difficile infection in children. Pediatr Infect Dis J
2012;31(2):134–138.
18.
Kuijper, EJ, Barbut, F, Brazier, JS, et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill
2008;13(31).
19.
McDonald, LC, Killgore, GE, Thompson, A, et al. An epidemic, toxin gene–variant strain of Clostridium difficile
. N Engl J Med
2005;353(23):2433–2441.
20.
Burns, DA, Heeg, D, Cartman, ST, Minton, NP. Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI/NAP1/027. PLoS ONE
2011;6(9):e24894.
21.
Merrigan, M, Venugopal, A, Mallozzi, M, et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol
2010;192(19):4904–4911.
22.
Warny, M, Pepin, J, Fang, A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet
2005;366(9491):1079–1084.
23.
Walker, AS, Eyre, DW, Wyllie, DH, et al. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis
2013;56(11):1589–1600.
24.
Black, SR, Weaver, KN, Jones, RC, et al.
Clostridium difficile outbreak strain BI is highly endemic in Chicago area hospitals. Infect Control Hosp Epidemiol
2011;32(9):897–902.
25.
Cheknis, AK, Sambol, SP, Davidson, DM, et al. Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005–2007. Anaerobe
2009;15(6):230–233.
26.
Lessa, FC. Incidence and insights into C. difficile infection epidemiology. ID Week. October 18, 2012.
27.
Dubberke, ER, Butler, AM, Reske, KA, et al. Attributable outcomes of endemic Clostridium difficile–associated disease in nonsurgical patients. Emerg Infect Dis
2008;14(7):1031–1038.
28.
Dubberke, ER, Olsen, MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis
2012;55(suppl 2):S88–S92.
29.
Hall, AJ, Curns, AT, McDonald, LC, Parashar, UD, Lopman, BA. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999–2007. Clin Infect Dis
2012;55(2):216–223.
30.
Sammons, JS, Localio, R, Xiao, R, Coffin, SE, Zaoutis, T.
Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children. Clin Infect Dis
2013;57(1):1–8.
31.
Pepin, J, Saheb, N, Coulombe, MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile–associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis
2005;41(9):1254–1260.
32.
Dial, S, Delaney, JA, Barkun, AN, Suissa, S. Use of gastric acid–suppressive agents and the risk of community-acquired Clostridium difficile–associated disease. JAMA
2005;294(23):2989–2995.
33.
Belmares, J, Gerding, DN, Parada, JP, Miskevics, S, Weaver, F, Johnson, S. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect
2007;55(6):495–501.
34.
Musher, DM, Aslam, S, Logan, N, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis
2005;40(11):1586–1590.
35.
Zar, FA, Bakkanagari, SR, Moorthi, KM, Davis, MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile–associated diarrhea, stratified by disease severity. Clin Infect Dis
2007;45(3):302–307.
36.
Kuijper, EJ, Coignard, B, Tull, P. Emergence of Clostridium difficile–associated disease in North America and Europe. Clin Microbiol Infect
2006;12(suppl 6):2–18.
37.
McDonald, LC, Coignard, B, Dubberke, E, Song, X, Horan, T, Kutty, PK. Recommendations for surveillance of Clostridium difficile–associated disease. Infect Control Hosp Epidemiol
2007;28(2):140–145.
38.
Dubberke, ER, Han, Z, Bobo, L, et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol
2011;49(8):2887–2893.
39.
Pepin, J, Valiquette, L, Cossette, B. Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ
2005;173(9):1037–1042.
40.
Dubberke, ER, Butler, AM, Hota, B, et al. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol
2009;30(6):518–525.
41.
Longtin, Y, Trottier, S, Brochu, G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis
2013;56(1):67–73.
42.
Planche, TD, Davies, KA, Coen, PG, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis
2013;13(11):936–945.
43.
Dubberke, ER, Reske, KA, McDonald, LC, Fraser, VJ. ICD-9 codes and surveillance for Clostridium difficile–associated disease. Emerg Infect Dis
2006;12(10):1576–1579.
44.
Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol
2010;31(5):431–455.
45.
Litvin, M, Reske, KA, Mayfield, J, et al. Identification of a pseudo-outbreak of Clostridium difficile infection (CDI) and the effect of repeated testing, sensitivity, and specificity on perceived prevalence of CDI. Infect Control Hosp Epidemiol
2009;30(12):1166–1171.
46.
Polage, CR, Chin, DL, Leslie, JL, Tang, J, Cohen, SH, Solnick, JV. Outcomes in patients tested for Clostridium difficile toxins. Diagn Microbiol Infect Dis
2012;74(4):369–373.
47.
Dubberke, ER Jr, Nyazee, HA, Yokoe, DS, et al. Implementing automated surveillance for tracking Clostridium difficile infection at multiple healthcare facilities. Infect Control Hosp Epidemiol
2012;33(3):305–308.
48.
Gase, KA, Haley, VB, Xiong, K, Van Antwerpen, C, Stricof, RL. Comparison of 2 Clostridium difficile surveillance methods: National Healthcare Safety Network’s laboratory-identified event reporting module versus clinical infection surveillance. Infect Control Hosp Epidemiol
2013;34(3):284–290.
49.
Bauer, MP, Kuijper, EJ, van Dissel, JT. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect
2009;15(12):1067–1079.
50.
Simor, AE, Bradley, SF, Strausbaugh, LJ, Crossley, K, Nicolle, LE.
Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol
2002;23(11):696–703.
51.
Surawicz, CM, Brandt, LJ, Binion, DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol
2013;108(4):478–498.
52.
Harris, AD, Bradham, DD, Baumgarten, M, Zuckerman, IH, Fink, JC, Perencevich, EN. The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis
2004;38(11):1586–1591.
53.
Stone, SP, Cooper, BS, Kibbler, CC, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis
2007;7(4):282–288.
54.
Fowler, S, Webber, A, Cooper, BS, et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J Antimicrob Chemother
2007;59(5):990–995.
55.
Valiquette, L, Cossette, B, Garant, MP, Diab, H, Pepin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile–associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis
2007;45(suppl 2):S112–S121.
56.
Aldeyab, MA, Kearney, MP, Scott, MG, et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother
2012;67(12):2988–2996.
57.
Talpaert, MJ, Gopal, RG, Cooper, BS, Wade, P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother
2011;66(9):2168–2174.
58.
Guerrero, DM, Nerandzic, MM, Jury, LA, Jinno, S, Chang, S, Donskey, CJ. Acquisition of spores on gloved hands after contact with the skin of patients with Clostridium difficile infection and with environmental surfaces in their rooms. Am J Infect Control
2012;40(6):556–558.
59.
McFarland, LV, Mulligan, ME, Kwok, RY, Stamm, WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med
1989;320(4):204–210.
60.
Stiefel, U, Cadnum, JL, Eckstein, BC, Guerrero, DM, Tima, MA, Donskey, CJ. Contamination of hands with methicillin-resistant Staphylococcus aureus after contact with environmental surfaces and after contact with the skin of colonized patients. Infect Control Hosp Epidemiol
2011;32(2):185–187.
61.
Hayden, MK, Blom, DW, Lyle, EA, Moore, CG, Weinstein, RA. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant Enterococcus or the colonized patients’ environment. Infect Control Hosp Epidemiol
2008;29(2):149–154.
62.
Boyce, JM, Ligi, C, Kohan, C, Dumigan, D, Havill, NL. Lack of association between the increased incidence of Clostridium difficile–associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol
2006;27(5):479–483.
63.
Gopal, RG, Jeanes, A, Osman, M, Aylott, C, Green, J. Marketing hand hygiene in hospitals—a case study. J Hosp Infect
2002;50(1):42–47.
64.
Gordin, FM, Schultz, ME, Huber, RA, Gill, JA. Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect Control Hosp Epidemiol
2005;26(7):650–653.
65.
Kaier, K, Hagist, C, Frank, U, Conrad, A, Meyer, E. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol
2009;30(4):346–353.
66.
Knight, N, Strait, T, Anthony, N, et al.
Clostridium difficile colitis: a retrospective study of incidence and severity before and after institution of an alcohol-based hand rub policy. Am J Infect Control
2010;38(7):523–528.
67.
Rupp, ME, Fitzgerald, T, Puumala, S, et al. Prospective, controlled, cross-over trial of alcohol-based hand gel in critical care units. Infect Control Hosp Epidemiol
2008;29(1):8–15.
68.
Vernaz, N, Sax, H, Pittet, D, Bonnabry, P, Schrenzel, J, Harbarth, S. Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile
. J Antimicrob Chemother
2008;62(3):601–607.
69.
Shaughnessy, MK, Micielli, RL, Depestel, DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol
2011;32(3):201–206.
70.
Chang, VT, Nelson, K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis
2000;31(3):717–722.
71.
Clabots, CR, Johnson, S, Olson, MM, Peterson, LR, Gerding, DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis
1992;166(3):561–567.
72.
Samore, MH, Venkataraman, L, DeGirolami, PC, Arbeit, RD, Karchmer, AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med
1996;100(1):32–40.
73.
Boyce, JM, Havill, NL, Otter, JA, et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol
2008;29(8):723–729.
74.
Mayfield, JL, Leet, T, Miller, J, Mundy, LM. Environmental control to reduce transmission of Clostridium difficile
. Clin Infect Dis
2000;31(4):995–1000.
75.
Wilcox, MH, Fawley, WN, Wigglesworth, N, Parnell, P, Verity, P, Freeman, J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect
2003;54(2):109–114.
76.
Simor, AE. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review. J Am Geriatr Soc
2010;58(8):1556–1564.
77.
Boyce, JM, Pittet, D;
Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control, and Infectious Diseases Society of America. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep
2002;51(RR-16):1–45.
78.
Loo, VG, Bourgault, AM, Poirier, L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med
2011;365(18):1693–1703.
79.
Doernberg, SB, Winston, LG, Deck, DH, Chambers, HF. Does doxycycline protect against development of Clostridium difficile infection? Clin Infect Dis
2012;55(5):615–620.
80.
Le, F, Arora, V, Shah, DN, Salazar, M, Palmer, HR, Garey, KW. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs. Pharmacotherapy
2012;32(2):129–134.
81.
Harpe, SE, Inocencio, TJ, Pakyz, AL, Oinonen, MJ, Polk, RE. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship. Pharmacotherapy
2012;32(8):744–754.
82.
Frequently asked questions about Clostridium difficile for healthcare providers. Centers for Disease Control and Prevention website. 2005. http://www.cdc.gov/HAI/organisms/cdiff/Cdiff_faqs_HCP.html.
83.
Sethi, AK, Al Nassir, WN, Nerandzic, MM, Bobulsky, GS, Donskey, CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol
2010;31(1):21–27.
84.
Dubberke, ER, Reske, KA, Noble-Wang, J, et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control
2007;35(5):315–318.
85.
Dumford, DM III, Nerandzic, MM, Eckstein, BC, Donskey, CJ. What is on that keyboard? detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. Am J Infect Control
2009;37(1):15–19.
86.
Lewis, AM, Gammon, J, Hosein, I. The pros and cons of isolation and containment. J Hosp Infect
1999;43(1):19–23.
87.
Jabbar, U, Leischner, J, Kasper, D, et al. Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol
2010;31(6):565–570.
88.
Oughton, MT, Loo, VG, Dendukuri, N, Fenn, S, Libman, MD. Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile
. Infect Control Hosp Epidemiol
2009;30(10):939–944.
89.
Edmonds, SL, Zapka, C, Kasper, D, et al. Effectiveness of hand hygiene for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol
2013;34(3):302–305.
90.
Boyce, JM, Havill, NL, Dumigan, DG, Golebiewski, M, Balogun, O, Rizvani, R. Monitoring the effectiveness of hospital cleaning practices by use of an adenosine triphosphate bioluminescence assay. Infect Control Hosp Epidemiol
2009;30(7):678–684.
91.
Carling, PC, Parry, MF, Von Beheren, SM. Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol
2008;29(1):1–7.
92.
Sitzlar, B, Deshpande, A, Fertelli, D, Kundrapu, S, Sethi, AK, Donskey, CJ. An environmental disinfection odyssey: evaluation of sequential interventions to improve disinfection of Clostridium difficile isolation rooms. Infect Control Hosp Epidemiol
2013;34(5):459–465.
93.
Wilcox, MH, Fawley, WN, Parnell, P. Value of lysozyme agar incorporation and alkaline thioglycollate exposure for the environmental recovery of Clostridium difficile
. J Hosp Infect
2000;44(1):65–69.
94.
Abbett, SK, Yokoe, DS, Lipsitz, SR, et al. Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol
2009;30(11):1062–1069.
95.
McMullen, KM, Zack, J, Coopersmith, CM, Kollef, M, Dubberke, E, Warren, DK. Use of hypochlorite solution to decrease rates of Clostridium difficile–associated diarrhea. Infect Control Hosp Epidemiol
2007;28(2):205–207.
96.
Mermel, LA, Jefferson, J, Blanchard, K, et al. Reducing Clostridium difficile incidence, colectomies, and mortality in the hospital setting: a successful multidisciplinary approach. Jt Comm J Qual Patient Saf
2013;39(7):298–305.
97.
Orenstein, R, Aronhalt, KC, McManus JE Jr, Fedraw, LA. A targeted strategy to wipe out Clostridium difficile
. Infect Control Hosp Epidemiol
2011;32(11):1137–1139.
98.
Kundrapu, S, Sunkesula, V, Jury, LA, Sitzlar, BM, Donskey, CJ. Daily disinfection of high-touch surfaces in isolation rooms to reduce contamination of healthcare workers’ hands. Infect Control Hosp Epidemiol
2012;33(10):1039–1042.
99.
Kallen, AJ, Thompson, A, Ristaino, P, et al. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol
2009;30(3):264–272.
100.
McNulty, C, Logan, M, Donald, IP, et al. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. J Antimicrob Chemother
1997;40(5):707–711.
101.
Pear, SM, Williamson, TH, Bettin, KM, Gerding, DN, Galgiani, JN. Decrease in nosocomial Clostridium difficile–associated diarrhea by restricting clindamycin use. Ann Intern Med
1994;120(4):272–277.
102.
Johnson, S, Homann, SR, Bettin, KM, et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole: a randomized, placebo-controlled trial. Ann Intern Med
1992;117(4):297–302.
103.
Kirkland, KB, Weinstein, JM. Adverse effects of contact isolation. Lancet
1999;354(9185):1177–1178.
104.
Morgan, DJ, Diekema, DJ, Sepkowitz, K, Perencevich, EN. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control
2009;37(2):85–93.
105.
Saint, S, Higgins, LA, Nallamothu, BK, Chenoweth, C. Do physicians examine patients in contact isolation less frequently? a brief report. Am J Infect Control
2003;31(6):354–356.
106.
Stelfox, HT, Bates, DW, Redelmeier, DA. Safety of patients isolated for infection control. JAMA
2003;290(14):1899–1905.
107.
McFarland, LV, Elmer, GW, Surawicz, CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol
2002;97(7):1769–1775.
108.
Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control
2007;35(10 suppl 2):S65–S164.
109.
Goldenberg, JZ, Ma, SS, Saxton, JD, et al. Probiotics for the prevention of Clostridium difficile–associated diarrhea in adults and children. Cochrane Database Syst Rev
2013;5:CD006095.
110.
Johnston, BC, Ma, SS, Goldenberg, JZ, et al. Probiotics for the prevention of Clostridium difficile–associated diarrhea: a systematic review and meta-analysis. Ann Intern Med
2012;157(12):878–888.
111.
Dubberke, ER, Yan, Y, Reske, KA, et al. Development and validation of a Clostridium difficile infection risk prediction model. Infect Control Hosp Epidemiol
2011;32(4):360–366.
112.
Gupta, S, Miller, M, Mehta, V, et al. A large prospective North American epidemiologic study of hospital-associated Clostridium difficile colonization and infection. International Clostridium difficile Symposium; Bled, Slovenia; abstract O20. September 22, 2012.
113.
Allen, SJ, Wareham, K, Wang, D, et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet
2013;382(9900):1249–1257.
114.
Munoz, P, Bouza, E, Cuenca-Estrella, M, et al.
Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis
2005;40(11):1625–1634.
115.
Barbut, F, Menuet, D, Verachten, M, Girou, E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol
2009;30(6):507–514.
116.
Wong, SK, Kneebone, A, Morgan, M, Henderson, CJ, Morgan, A, Jalaludin, B. Surgical management of colorectal cancer in south-western Sydney 1997–2001: a prospective series of 1293 unselected cases from six public hospitals. ANZ J Surg
2005;75(9):776–782.
117.
McKibben, L, Horan, TC, Tokars, JI, et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol
2005;26(6):580–587.
118.
Berenholtz, SM, Pham, JC, Thompson, DA, et al. Collaborative cohort study of an intervention to reduce ventilator-associated pneumonia in the intensive care unit. Infect Control Hosp Epidemiol
2011;32(4):305–314.
119.
Farley, JE, Doughman, D, Jeeva, R, Jeffries, P, Stanley, JM. Department of Health and Human Services releases new immersive simulation experience to improve infection control knowledge and practices among health care workers and students. Am J Infect Control
2012;40(3):258–259.
120.
Landers, T, Abusalem, S, Coty, MB, Bingham, J. Patient-centered hand hygiene: the next step in infection prevention. Am J Infect Control
2012;40(4 suppl 1):S11–S17.
121.
Dubberke, ER. Prevention of healthcare-associated Clostridium difficile infection: what works? Infect Control Hosp Epidemiol
2010;31(suppl 1):S38–S41.
122.
Guyatt, GH, Oxman, AD, Vist, GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ
2008;336(7650):924–926.
123.
GRADE. Canadian Task Force on Preventive Health Care website. http://canadiantaskforce.ca/methods/grade/. Accessed December 31, 2013.
